Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
The report details the trend, potential and market size of Hodgkin Lymphoma Treatment market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.
The first part (Chapter1-7) mainly covers the qualitative analysis of Hodgkin Lymphoma Treatmentmarket, defines the market attractiveness level of Hodgkin Lymphoma Treatment market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.
The second part (Chapter8-12), based on the segmentation of Hodgkin Lymphoma Treatment industry, describes the types of Hodgkin Lymphoma Treatment market, the applications of major players and the market size, and deeply analyzes the current situation of the global Hodgkin Lymphoma Treatment market and the development prospects and opportunities of Hodgkin Lymphoma Treatment industry.
The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.
As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Hodgkin Lymphoma Treatment market in Chapter 13.
By Player:
NantKwest, Inc
Constellation Pharmaceuticals, Inc
Mirati Therapeutics Inc
Molecular Templates Inc
Gamida Cell Ltd
Fate Therapeutics, Inc
Gilead Sciences, Inc
Cellular Biomedicine Group, Inc
Curis, Inc
Merck & Co, Inc
Incyte Corporation
Cell Medica Limited
Faron Pharmaceuticals Oy
By Type:
Alocrest
ANK Program
Azacitidine
BMS-986016
BPX-501
Others
By End-User:
Hospital
Clinic
Research Center
By Geography:
-
United States
-
Europe
-
China
-
Japan
-
India
-
South Korea
TABLE OF CONTENT
1 Introduction
-
1.1 Market Definition
-
1.2 Market Segment Analysis
-
1.3 Market Size 2022
-
1.4 Hodgkin Lymphoma Treatment Market Outlook: Forecast for 2022 - 2028
-
1.5 Pricing Analysis
2 Executive Summary
3 Hodgkin Lymphoma Treatment Market Lineage Outlook
-
3.1 Parent Market Outlook
-
3.2 Related/Ancillary Market Outlook
-
3.3 Penetration & Growth Prospect Mapping, 2022
4 Market Analysis Tools: Porter's Five Forces
-
4.1 Supplier Power
-
4.2 Buyer Power
-
4.3 Substitution Threat
-
4.4 Threat of New Entrants
-
4.5 Competitive Rivalry
5 Hodgkin Lymphoma Treatment Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)
-
5.1 Political/Legal Landscape
-
5.2 Economic Landscape
-
5.3 Social Landscape
-
5.4 Technology Landscape
6 Hodgkin Lymphoma Treatment Market - Value Chain Analysis
-
6.1 Industry's Value Chain Analysis
-
6.2 Product Life Cycle
-
6.3 User Perspective Analysis
7 Region and Country-wise Hodgkin Lymphoma Treatment Market Analysis and Outlook to 2022
-
7.1 Global Hodgkin Lymphoma Treatment Consumption (2017-2022)
-
7.2 United States Hodgkin Lymphoma Treatment Consumption (2017-2022)
-
7.3 Europe Hodgkin Lymphoma Treatment Consumption (2017-2022)
-
7.4 China Hodgkin Lymphoma Treatment Consumption (2017-2022)
-
7.5 Japan Hodgkin Lymphoma Treatment Consumption (2017-2022)
-
7.6 India Hodgkin Lymphoma Treatment Consumption (2017-2022)
-
7.7 South Korea Hodgkin Lymphoma Treatment Consumption (2017-2022)
8 Region and Country-wise Hodgkin Lymphoma Treatment Market Analysis and Outlook to 2028
-
8.1 Global Hodgkin Lymphoma Treatment Consumption Forecast (2022-2028)
-
8.2 United States Hodgkin Lymphoma Treatment Consumption Forecast (2022-2028)
-
8.3 Europe Hodgkin Lymphoma Treatment Consumption Forecast (2022-2028)
-
8.4 China Hodgkin Lymphoma Treatment Consumption Forecast (2022-2028)
-
8.5 Japan Hodgkin Lymphoma Treatment Consumption Forecast (2022-2028)
-
8.6 India Hodgkin Lymphoma Treatment Consumption Forecast (2022-2028)
-
8.7 South Korea Hodgkin Lymphoma Treatment Consumption Forecast (2022-2028)
9 Global Hodgkin Lymphoma Treatment Market Outlook by Types and Applications to 2022
-
9.1 Global Hodgkin Lymphoma Treatment Consumption and Growth Rate by Type (2017-2022)
-
9.1.1 Global Alocrest Consumption and Growth Rate (2017-2022)
-
9.1.2 Global ANK Program Consumption and Growth Rate (2017-2022)
-
9.1.3 Global Azacitidine Consumption and Growth Rate (2017-2022)
-
9.1.4 Global BMS-986016 Consumption and Growth Rate (2017-2022)
-
9.1.5 Global BPX-501 Consumption and Growth Rate (2017-2022)
-
9.1.6 Global Others Consumption and Growth Rate (2017-2022)
-
9.2 Global Hodgkin Lymphoma Treatment Consumption and Growth Rate by Application (2017-2022)
-
9.2.1 Global Hospital Consumption and Growth Rate (2017-2022)
-
9.2.2 Global Clinic Consumption and Growth Rate (2017-2022)
-
9.2.3 Global Research Center Consumption and Growth Rate (2017-2022)
10 Global Hodgkin Lymphoma Treatment Market Outlook by Types and Applications to 2028
-
10.1 Global Hodgkin Lymphoma Treatment Consumption Forecast and Growth Rate by Type (2022-2028)
-
10.1.1 Global Alocrest Consumption Forecast and Growth Rate (2022-2028)
-
10.1.2 Global ANK Program Consumption Forecast and Growth Rate (2022-2028)
-
10.1.3 Global Azacitidine Consumption Forecast and Growth Rate (2022-2028)
-
10.1.4 Global BMS-986016 Consumption Forecast and Growth Rate (2022-2028)
-
10.1.5 Global BPX-501 Consumption Forecast and Growth Rate (2022-2028)
-
10.1.6 Global Others Consumption Forecast and Growth Rate (2022-2028)
-
10.2 Global Hodgkin Lymphoma Treatment Consumption Forecast and Growth Rate by Application (2022-2028)
-
10.2.1 Global Hospital Consumption Forecast and Growth Rate (2022-2028)
-
10.2.2 Global Clinic Consumption Forecast and Growth Rate (2022-2028)
-
10.2.3 Global Research Center Consumption Forecast and Growth Rate (2022-2028)
11 Global Hodgkin Lymphoma Treatment Import and Export Analysis (Top 5 Countries)
-
11.1 Global Hodgkin Lymphoma Treatment Import by Region (Top 5 Countries) (2017-2028)
-
11.2 Global Hodgkin Lymphoma Treatment Export by Region (Top 5 Countries) (2017-2028)
12 Coronavirus Disease (COVID-19) Impact
-
12.1 Industry Impact Analysis
-
12.2 Hodgkin Lymphoma Treatment Market Outlook to 2028 - COVID-19 Affected Forecasts
13 Competition Matrix
-
13.1 Target Markets
-
13.2 Comprehensive Analysis of Products in Competitive Markets
14 Global Hodgkin Lymphoma Treatment Market Competitive Analysis
-
14.1 NantKwest, Inc
-
14.1.1 NantKwest, Inc Company Details
-
14.1.2 NantKwest, Inc Hodgkin Lymphoma Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
14.1.3 NantKwest, Inc Hodgkin Lymphoma Treatment Product and Service
-
14.2 Constellation Pharmaceuticals, Inc
-
14.2.1 Constellation Pharmaceuticals, Inc Company Details
-
14.2.2 Constellation Pharmaceuticals, Inc Hodgkin Lymphoma Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
14.2.3 Constellation Pharmaceuticals, Inc Hodgkin Lymphoma Treatment Product and Service
-
14.3 Mirati Therapeutics Inc
-
14.3.1 Mirati Therapeutics Inc Company Details
-
14.3.2 Mirati Therapeutics Inc Hodgkin Lymphoma Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
14.3.3 Mirati Therapeutics Inc Hodgkin Lymphoma Treatment Product and Service
-
14.4 Molecular Templates Inc
-
14.4.1 Molecular Templates Inc Company Details
-
14.4.2 Molecular Templates Inc Hodgkin Lymphoma Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
14.4.3 Molecular Templates Inc Hodgkin Lymphoma Treatment Product and Service
-
14.5 Gamida Cell Ltd
-
14.5.1 Gamida Cell Ltd Company Details
-
14.5.2 Gamida Cell Ltd Hodgkin Lymphoma Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
14.5.3 Gamida Cell Ltd Hodgkin Lymphoma Treatment Product and Service
-
14.6 Fate Therapeutics, Inc
-
14.6.1 Fate Therapeutics, Inc Company Details
-
14.6.2 Fate Therapeutics, Inc Hodgkin Lymphoma Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
14.6.3 Fate Therapeutics, Inc Hodgkin Lymphoma Treatment Product and Service
-
14.7 Gilead Sciences, Inc
-
14.7.1 Gilead Sciences, Inc Company Details
-
14.7.2 Gilead Sciences, Inc Hodgkin Lymphoma Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
14.7.3 Gilead Sciences, Inc Hodgkin Lymphoma Treatment Product and Service
-
14.8 Cellular Biomedicine Group, Inc
-
14.8.1 Cellular Biomedicine Group, Inc Company Details
-
14.8.2 Cellular Biomedicine Group, Inc Hodgkin Lymphoma Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
14.8.3 Cellular Biomedicine Group, Inc Hodgkin Lymphoma Treatment Product and Service
-
14.9 Curis, Inc
-
14.9.1 Curis, Inc Company Details
-
14.9.2 Curis, Inc Hodgkin Lymphoma Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
14.9.3 Curis, Inc Hodgkin Lymphoma Treatment Product and Service
-
14.10 Merck & Co, Inc
-
14.10.1 Merck & Co, Inc Company Details
-
14.10.2 Merck & Co, Inc Hodgkin Lymphoma Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
14.10.3 Merck & Co, Inc Hodgkin Lymphoma Treatment Product and Service
-
14.11 Incyte Corporation
-
14.11.1 Incyte Corporation Company Details
-
14.11.2 Incyte Corporation Hodgkin Lymphoma Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
14.11.3 Incyte Corporation Hodgkin Lymphoma Treatment Product and Service
-
14.12 Cell Medica Limited
-
14.12.1 Cell Medica Limited Company Details
-
14.12.2 Cell Medica Limited Hodgkin Lymphoma Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
14.12.3 Cell Medica Limited Hodgkin Lymphoma Treatment Product and Service
-
14.13 Faron Pharmaceuticals Oy
-
14.13.1 Faron Pharmaceuticals Oy Company Details
-
14.13.2 Faron Pharmaceuticals Oy Hodgkin Lymphoma Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
14.13.3 Faron Pharmaceuticals Oy Hodgkin Lymphoma Treatment Product and Service
15 Appendix
TABLE OF CHARTS
-
Table Definition of Hodgkin Lymphoma Treatment
-
Figure Hodgkin Lymphoma Treatment Picture
-
Table Global Hodgkin Lymphoma Treatment Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Hodgkin Lymphoma Treatment Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Hodgkin Lymphoma Treatment Market: Year-over-year Growth 2022 - 2028 (%)
-
Table Parent Market Analysis
-
Figure Parent Market Price
-
Table Related/Ancillary Market Outlook Analysis
-
Table Supplier Power Analysis
-
Table Buyer Power Analysis
-
Table Substitution Threat Analysis
-
Table Threat of New Entrants Analysis
-
Table Competitive Rivalry Analysis
-
Figure Global Hodgkin Lymphoma Treatment Consumption by Country (2017-2022)
-
Figure United States Hodgkin Lymphoma Treatment Consumption and Growth Rate (2017-2022)
-
Table Europe Hodgkin Lymphoma Treatment Consumption and Growth Rate (2017-2022)
-
Figure China Hodgkin Lymphoma Treatment Consumption and Growth Rate (2017-2022)
-
Figure Japan Hodgkin Lymphoma Treatment Consumption and Growth Rate (2017-2022)
-
Figure India Hodgkin Lymphoma Treatment Consumption and Growth Rate (2017-2022)
-
Figure South Korea Hodgkin Lymphoma Treatment Consumption and Growth Rate (2017-2022)
-
Figure Global Hodgkin Lymphoma Treatment Consumption Forecast by Country (2022-2028)
-
Figure United States Hodgkin Lymphoma Treatment Consumption Forecast and Growth Rate (2022-2028)
-
Table Europe Hodgkin Lymphoma Treatment Consumption Forecast and Growth Rate (2022-2028)
-
Figure China Hodgkin Lymphoma Treatment Consumption Forecast and Growth Rate (2022-2028)
-
Figure Japan Hodgkin Lymphoma Treatment Consumption Forecast and Growth Rate (2022-2028)
-
Figure India Hodgkin Lymphoma Treatment Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Korea Hodgkin Lymphoma Treatment Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Alocrest Consumption and Growth Rate (2017-2022)
-
Figure Global ANK Program Consumption and Growth Rate (2017-2022)
-
Figure Global Azacitidine Consumption and Growth Rate (2017-2022)
-
Figure Global BMS-986016 Consumption and Growth Rate (2017-2022)
-
Figure Global BPX-501 Consumption and Growth Rate (2017-2022)
-
Figure Global Others Consumption and Growth Rate (2017-2022)
-
Figure Global Hospital Consumption and Growth Rate (2017-2022)
-
Figure Global Clinic Consumption and Growth Rate (2017-2022)
-
Figure Global Research Center Consumption and Growth Rate (2017-2022)
-
Figure Global Alocrest Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global ANK Program Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Azacitidine Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global BMS-986016 Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global BPX-501 Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Others Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Hospital Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Clinic Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Research Center Consumption Forecast and Growth Rate (2022-2028)
-
Table Global Hodgkin Lymphoma Treatment Import by Region (Top 5 Countries) (2017-2028)
-
Table Global Hodgkin Lymphoma Treatment Export by Region (Top 5 Countries) (2017-2028)
-
Table NantKwest, Inc (Foundation Year, Company Profile and etc.)
-
Table NantKwest, Inc Hodgkin Lymphoma Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
Table NantKwest, Inc Hodgkin Lymphoma Treatment Product and Service
-
Table Constellation Pharmaceuticals, Inc (Foundation Year, Company Profile and etc.)
-
Table Constellation Pharmaceuticals, Inc Hodgkin Lymphoma Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
Table Constellation Pharmaceuticals, Inc Hodgkin Lymphoma Treatment Product and Service
-
Table Mirati Therapeutics Inc (Foundation Year, Company Profile and etc.)
-
Table Mirati Therapeutics Inc Hodgkin Lymphoma Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
Table Mirati Therapeutics Inc Hodgkin Lymphoma Treatment Product and Service
-
Table Molecular Templates Inc (Foundation Year, Company Profile and etc.)
-
Table Molecular Templates Inc Hodgkin Lymphoma Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
Table Molecular Templates Inc Hodgkin Lymphoma Treatment Product and Service
-
Table Gamida Cell Ltd (Foundation Year, Company Profile and etc.)
-
Table Gamida Cell Ltd Hodgkin Lymphoma Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
Table Gamida Cell Ltd Hodgkin Lymphoma Treatment Product and Service
-
Table Fate Therapeutics, Inc (Foundation Year, Company Profile and etc.)
-
Table Fate Therapeutics, Inc Hodgkin Lymphoma Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
Table Fate Therapeutics, Inc Hodgkin Lymphoma Treatment Product and Service
-
Table Gilead Sciences, Inc (Foundation Year, Company Profile and etc.)
-
Table Gilead Sciences, Inc Hodgkin Lymphoma Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
Table Gilead Sciences, Inc Hodgkin Lymphoma Treatment Product and Service
-
Table Cellular Biomedicine Group, Inc (Foundation Year, Company Profile and etc.)
-
Table Cellular Biomedicine Group, Inc Hodgkin Lymphoma Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
Table Cellular Biomedicine Group, Inc Hodgkin Lymphoma Treatment Product and Service
-
Table Curis, Inc (Foundation Year, Company Profile and etc.)
-
Table Curis, Inc Hodgkin Lymphoma Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
Table Curis, Inc Hodgkin Lymphoma Treatment Product and Service
-
Table Merck & Co, Inc (Foundation Year, Company Profile and etc.)
-
Table Merck & Co, Inc Hodgkin Lymphoma Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
Table Merck & Co, Inc Hodgkin Lymphoma Treatment Product and Service
-
Table Incyte Corporation (Foundation Year, Company Profile and etc.)
-
Table Incyte Corporation Hodgkin Lymphoma Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
Table Incyte Corporation Hodgkin Lymphoma Treatment Product and Service
-
Table Cell Medica Limited (Foundation Year, Company Profile and etc.)
-
Table Cell Medica Limited Hodgkin Lymphoma Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
Table Cell Medica Limited Hodgkin Lymphoma Treatment Product and Service
-
Table Faron Pharmaceuticals Oy (Foundation Year, Company Profile and etc.)
-
Table Faron Pharmaceuticals Oy Hodgkin Lymphoma Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
Table Faron Pharmaceuticals Oy Hodgkin Lymphoma Treatment Product and Service
-
